hc1 + Accumen Banner
Healthcare Progress Starts Here:TM hc1 + Accumen Merge

Healthcare Progress Starts Here™

With hc1 + Accumen

We establish the lab as a strategic asset for health systems by combining advanced information technology with world-renowned expertise.

Our Clients

What Our Clients Say...

Tangible Results

$150M+

Annualized Savings in Supply Chain expenses for our partners

$120M+

Annualized Savings in Lab Labor expenses for our partners

1,900+

Avoided Transfusion Associated Deaths from Clinical Transformation

Lab Operations and Clinical Transformation

Lab Operations Management

Assure your lab is operating at its most efficient level. Increase your productivity in an era of staffing and supply shortages, improve your quality and service thereby increasing patient satisfaction and understand your options for new sources of revenue.  Accumen’s expert lab consultants can assess, recommend, and implement your transformational projects. Transform your clinical lab and you will transform the core of your healthcare delivery capabilities.

Lab Operations

Clinical Transformation

The rising cost of care for complex patients, critical blood shortages, and the expanding list of adverse events associated with untreated anemia and blood transfusions are driving a global focus on comprehensive Patient Blood Management. 

Accumen’s internationally recognized clinical experts utilize an evidence-based, “patient-centered” approach designed to manage and preserve the patient’s own blood, significantly reducing transfusion exposure, improving outcomes, and reducing overall costs. 

Upcoming Webinar

Lab Planning: Do We Keep, Sell, Partner or Outsource Our Lab

Our Presenters:

Bradley Bostic
Chairman & CEO
jeff-myers-v2
Jeff Myers, CPA
VP/GM of Consulting

Explore the current hospital laboratory market, including the number of and multiples for laboratory sales, laboratory management outsourcing and joint ventures. The various factors driving the market will be addressed. The program will provide recommendations on how to best assess the going forward strategies for your lab, including continuing to run your own lab or undertaking a third-party transaction.